450 related articles for article (PubMed ID: 12494883)
1. Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects.
Minev BR; Guo F; Gueorguieva I; Kaiser HE
In Vivo; 2002; 16(6):405-15. PubMed ID: 12494883
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: an update.
Hipp JD; Hipp JA; Lyday BW; Minev BR
In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541
[TBL] [Abstract][Full Text] [Related]
3. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
[TBL] [Abstract][Full Text] [Related]
4. Immunologic approaches to breast cancer treatment.
Sabel MS; Nehs MA
Surg Oncol Clin N Am; 2005 Jan; 14(1):1-31, v. PubMed ID: 15541997
[TBL] [Abstract][Full Text] [Related]
5. MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.
Yuan S; Shi C; Liu L; Han W
Expert Opin Biol Ther; 2010 Jul; 10(7):1037-48. PubMed ID: 20420512
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer vaccines: current status.
Hwang LC; Fein S; Levitsky H; Nelson WG
Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
[TBL] [Abstract][Full Text] [Related]
7. Current immunotherapeutic strategies in prostate cancer.
Grosso JF; Drake CG
Surg Oncol Clin N Am; 2007 Oct; 16(4):861-71, x. PubMed ID: 18022549
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer vaccines: promise for the future or pipe dream?
Mittendorf EA; Peoples GE; Singletary SE
Cancer; 2007 Oct; 110(8):1677-86. PubMed ID: 17763371
[TBL] [Abstract][Full Text] [Related]
9. New trends in the development of cancer vaccines.
Minev BR; Chavez FL; Mitchell MS
In Vivo; 1998; 12(6):629-38. PubMed ID: 9891226
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines: a critical review on clinical impact.
Bitton RJ
Curr Opin Mol Ther; 2004 Feb; 6(1):17-26. PubMed ID: 15011777
[TBL] [Abstract][Full Text] [Related]
11. Immunology and breast cancer: therapeutic cancer vaccines.
Curigliano G; Rescigno M; Goldhirsch A
Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
[TBL] [Abstract][Full Text] [Related]
12. The immunotherapy of prostate and bladder cancer.
Totterman TH; Loskog A; Essand M
BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
[TBL] [Abstract][Full Text] [Related]
13. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic vaccines for prostate cancer: a review of clinical data.
Arlen PM; Gulley JL
Curr Opin Investig Drugs; 2005 Jun; 6(6):592-6. PubMed ID: 15988910
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines for the treatment of prostate cancer.
Alam S; McNeel DG
Expert Rev Vaccines; 2010 Jul; 9(7):731-45. PubMed ID: 20624047
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
Simons JW; Carducci MA; Mikhak B; Lim M; Biedrzycki B; Borellini F; Clift SM; Hege KM; Ando DG; Piantadosi S; Mulligan R; Nelson WG
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3394-401. PubMed ID: 16740763
[TBL] [Abstract][Full Text] [Related]
17. Vaccine therapy for cancer: fact or fiction?
Odunsi K; Lele S; Savalgi R
Surg Technol Int; 2004; 13():39-47. PubMed ID: 15744673
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
Acres B
J BUON; 2007 Sep; 12 Suppl 1():S71-5. PubMed ID: 17935281
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer immunotherapy.
McNeel DG
Curr Opin Urol; 2007 May; 17(3):175-81. PubMed ID: 17414515
[TBL] [Abstract][Full Text] [Related]
20. CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.
Lubaroff DM; Karan D
Adv Drug Deliv Rev; 2009 Mar; 61(3):268-74. PubMed ID: 19166887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]